Scarica l'app Stockscreener
0.109
12.84%
0.0124
Precedente Chiudi:
$0.0966
Aprire:
$0.107
Volume 24 ore:
31,531
Relative Volume:
10.80
Capitalizzazione di mercato:
$N/A
Reddito:
$7.10M
Utile/perdita netta:
$-39.43M
Rapporto P/E:
-0.116
EPS:
-0.94
Flusso di cassa netto:
$-46.50M
1 W Prestazione:
+12.84%
1M Prestazione:
-74.38%
6M Prestazione:
-86.69%
1 anno Prestazione:
-90.34%
Intervallo 1D:
$0.107
$0.119
Intervallo di 1 settimana:
$0.107
$0.119
Portata 52W:
$0.0966
$0.119
Spruce Biosciences Inc Stock (SPRB) Company Profile
Nome
Spruce Biosciences Inc
Settore
Industria
Telefono
-
Indirizzo
-
Confronta SPRB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SPRB
Spruce Biosciences Inc
|
0.109 | 0 | 7.10M | -39.43M | -46.50M | -0.94 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Spruce Biosciences Inc Stock (SPRB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-11 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-12-11 | Downgrade | Oppenheimer | Outperform → Perform |
| 2024-03-14 | Downgrade | Guggenheim | Buy → Neutral |
| 2024-03-14 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-03-14 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2024-03-14 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-03-14 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-02-21 | Iniziato | Guggenheim | Buy |
| 2021-12-17 | Iniziato | Oppenheimer | Outperform |
| 2021-12-10 | Iniziato | The Benchmark Company | Speculative Buy |
| 2021-11-16 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2021-07-19 | Iniziato | H.C. Wainwright | Buy |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2020-11-03 | Iniziato | Cowen | Outperform |
| 2020-11-03 | Iniziato | Credit Suisse | Outperform |
| 2020-11-03 | Iniziato | RBC Capital Mkts | Outperform |
| 2020-11-03 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Spruce Biosciences Inc Borsa (SPRB) Ultime notizie
Spruce Biosciences (NASDAQ:SPRB) Shares to Reverse Split on Monday, August 4th - Defense World
Spruce Biosciences Announces Reverse Stock Split Plan - The Globe and Mail
Spruce Biosciences to enact 1-for-75 reverse stock split - MSN
Spruce Biosciences to implement 1-for-75 reverse stock split - Investing.com
Spruce Biosciences Announces Reverse Stock Split - Business Wire
HMNC Brain Health and Spruce Biosciences Announce First Patient Dosed in Phase 2 TAMARIND Trial For Major Depressive Disorder - The Manila Times
Spruce Biosciences (SPRB) Advances in Phase 2 Depression Treatme - GuruFocus
Spruce Biosciences (NASDAQ:SPRB) Trading Up 5.7% – Here’s What Happened - Defense World
Layoff Tracker: Following Challenges With DMD Therapy, Sarepta Will Cut 500 Employees - BioSpace
Ultragenyx hit again, this time with a CRL in rare disease - BioWorld MedTech
Spruce Biosciences (SPRB) Gains Investor Attention with Significant Interest Surge | SPRB Stock News - GuruFocus
Spruce Biosciences gets conditional approval to resume trading on Nasdaq Capital Market - MSN
Spruce Biosciences (NASDAQ:SPRB) versus Pharmaxis (OTCMKTS:PXSLY) Head-To-Head Analysis - Defense World
Congenital Adrenal Hyperplasia Treatment Market Outlook Influenced by Gene Therapy Innovations 2025 - openPR.com
SPRB ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Spruce Biosciences, Inc. - ACCESS Newswire
BriaCell Therapeutics (OTCMKTS:BCTXF) vs. Spruce Biosciences (NASDAQ:SPRB) Head-To-Head Survey - Defense World
Congenital Adrenal Hyperplasia Pipeline Insight, 2025: - openPR.com
Spruce Biosciences (SPRB) Secures Nasdaq Approval for Relisting - GuruFocus
Spruce Biosciences Announces Conditional Nasdaq Approval to Resu - GuruFocus
# Spruce Biosciences to resume Nasdaq trading pending stock split approval By Investing.com - Investing.com South Africa
Spruce Biosciences Announces Conditional Nasdaq Approval to Resume Trading on the Nasdaq Capital Market - BioSpace
Spruce Biosciences regains Nasdaq compliance path By Investing.com - Investing.com South Africa
Spruce Biosciences regains Nasdaq compliance path - Investing.com
# Spruce Biosciences to resume Nasdaq trading pending stock split approval - Investing.com
Spruce Biosciences’ Compliance Plan Accepted by Nasdaq - TipRanks
Spruce Biosciences Announces Conditional Nasdaq Approval to Resume Trading on the Nasdaq Capital Market | SPRB Stock News - GuruFocus
Neurocrine Loses Suit Challenging Hormone Treatment Patent - Law360
Judge Tosses Neurocrine’s Suit Over Spruce Hormone-Drug Patent - Bloomberg Law News
Congenital Adrenal Hyperplasia Market Growth Projections - openPR.com
Berkshire Near All-time Highs: Could This Be Buffett's Final Defining Act? - The Globe and Mail
Time to Buy These 3 Cheap Stocks? - The Globe and Mail
If I Could Only Buy and Hold a Single Stock, This Would Be It - The Globe and Mail
Is Chipotle Mexican Grill Stock Underperforming the S&P 500? - The Globe and Mail
Is Palo Alto Networks Stock Outperforming the S&P 500? - The Globe and Mail
Is Amphenol Stock Outperforming the Dow? - The Globe and Mail
What Nvidia, AMD, and CoreWeave Stock Investors Should Know About the Recent AI Training Benchmark - The Globe and Mail
Spruce Biosciences Enters Purchase Agreement with Board Chair - TipRanks
Top 100 Stocks to Buy: Is Amer Sports Stock Ready to Head Downhill? - The Globe and Mail
FY2025 EPS Estimates for OTCMKTS:GTBIF Reduced by Analyst - Defense World
Axalta Coating Systems (NYSE:AXTA) Price Target Raised to $40.00 - Defense World
FY2025 EPS Estimates for InnovAge Decreased by William Blair - Defense World
Guggenheim Forecasts Strong Price Appreciation for Wingstop (NASDAQ:WING) Stock - Defense World
What is Seaport Res Ptn’s Forecast for FWONA Q3 Earnings? - Defense World
Spruce Biosciences (SPRB) Expected to Announce Quarterly Earnings on Monday - Defense World
Leerink Partnrs Issues Positive Outlook for SPRB Earnings - Defense World
Spruce Biosciences, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Spruce Biosciences (SPRB) - ACCESS Newswire
'It's a mess out there': More biotech layoffs mean stiff competition for jobs at emerging companies - The Business Journals
Renaissance Technologies LLC Reduces Stock Holdings in Spruce Biosciences, Inc. (NASDAQ:SPRB) - Defense World
Spruce Biosciences Inc Azioni (SPRB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.93%
0.15%
Capitalizzazione:
|
Volume (24 ore):